Active Switch From a Single Dose of Bimekizumab to Risankizumab in Psoriasis: A Pilot Study
Year: 2025
Type: article
Source: The Journal of Dermatology
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4409674097
